Bristol-Myers Squibb extends deal with DKSH in SE Asia

- Last updated on GMT

BMS extends deal with DKSH in SE Asia

Related tags: Southeast asia

Bristol-Myers Squibb has extended its partnership with DKSH to provide commercialization and distribution services across Southeast Asia.

Today the market expansion company announced it has extended a deal first penned in 2010 with BMS, focused on assisting the Big Pharma in growing its presence in Hong Kong, Malaysia, Singapore,Taiwan, Thailand and Vietnam.

This updated contract will see DKSH provide marketing, sales, warehousing, physical distribution, credit management and collection services for BMS across those six countries.

In the last few years, DKSH has won and extended a number of contracts with pharma companies looking to expand their presence in Southeast Asia. Nordic Biosciences​ was the latest to ink a deal for clinical trial logistics services in Hong Kong last December, joining Bayer​, Pfizer​, and GSK​, amongst others, in partnering with DKSH last year.

It is not only multinationals looking to expand their presence in the region but local firms too. In February, DKSH expanded by buying Macau-based distributor Glory and spokesman Michael Hofer told this publication​ this was due to “an increased demand for market expansion services from Asian pharma companies who are expanding their business in the region.”

Related news

Show more

Related products

Lessons Learned: Clinical Trials During a Pandemic

Lessons Learned: Clinical Trials During a Pandemic

PCM TRIALS | 01-Sep-2020 | Technical / White Paper

In a recent survey of clinical trial professionals (including pharmaceutical sponsors, CROs, site representatives and vendors), respondents reported that...

Local lab Data Management

Local lab Data Management

Q² Solutions | 01-May-2020 | Data Sheet

When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and...

Q2 Solutions: Corporate Brochure

Q2 Solutions: Corporate Brochure

Q² Solutions | 17-Apr-2020 | Product Brochure

We are an innovative, progressive and responsive partner with the global experience, medical expertise and focus on quality that is integral to drug, medical...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us


View more